Lantheus Holdings Inc. (NASDAQ:LNTH) fell 10.6% on Tuesday . The stock traded as low as $6.63 and last traded at $7.32, with a volume of 665,817 shares. The stock had previously closed at $8.19.

Several research firms recently weighed in on LNTH. Zacks Investment Research downgraded shares of Lantheus Holdings from a “buy” rating to a “hold” rating in a report on Thursday, May 12th. Jefferies Group reaffirmed a “buy” rating on shares of Lantheus Holdings in a report on Wednesday, May 4th. Finally, Credit Suisse Group AG set a $4.00 price target on shares of Lantheus Holdings and gave the stock a “hold” rating in a research report on Friday, August 5th. Three research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $5.80.

The firm has a market cap of $217.57 million and a PE ratio of 8.08. The company has a 50 day moving average of $5.33 and a 200 day moving average of $3.03.

Lantheus Holdings (NASDAQ:LNTH) last released its quarterly earnings data on Thursday, August 4th. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.18. The company had revenue of $78 million for the quarter, compared to analyst estimates of $72.66 million. On average, equities analysts anticipate that Lantheus Holdings Inc. will post $0.54 EPS for the current year.

Lantheus Holdings, Inc develops, manufactures and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. The Company’s portfolio of approximately 10 commercial products is spread across a range of imaging modalities.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.